Why Gabapentin is Now a Schedule 5 Controlled Substance in Two States
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- “Michigan Lists Pain Drug Gabapentin as Controlled Substance,” Associated Press, WXYZ-Detroit ABC, January 10, 2019. Retrieved from: https://www.wxyz.com/news/michigan-lists-pain-drug-gabapentin-as-controlled-substance
- “Should Gabapentin be a Controlled Substance?” by Pat Anson, Pain News Network, February 23, 2018. Retrieved from: https://www.painnewsnetwork.org/stories/2018/2/23/should-gabapentin-be-a-controlled-substance
- “Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance,” by Alyssa M Peckham, Maria J Ananickal, and David A Sclar, US National Library of Medicine, NIH. Journal List: Risk Manag Healthc Policy. 2018; 11: 109–116, Published online 2018 Aug 17. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103607/
- “Should the Schedule Change on Gabapentin?” by Shelby Leheny, Pharm D, BS, Pharmacy Times, January 12, 2017. Retrieved from: https://www.pharmacytimes.com/contributor/shelby-leheny-pharmd-candidate-2017/2017/01/should-the-schedule-change-on-gabapentin
- Gabapentin (Neurontin), Drug Enforcement Administration (DEA), Diversion Control Division, Drug & Chemical Evaluation Section. October, 2018. Retrieved from: https://www.deadiversion.usdoj.gov/drug_chem_info/gabapentin.pdf